Howard Kaufman

Company: Ankyra Therapeutics

Job title: President & Chief Executive Officer

Seminars:

Anchored Immunotherapy as a Strategy for Targeting Cytokine Retention in the Tumor Microenvironment to Promote Tumor Regression Without Systemic Toxicity 3:30 pm

• How Anchored immunotherapy is a novel drug delivery strategy that promotes local cytokine retention of and limits systemic diffusion • How Anchored immunotherapy can increase the therapeutic window for immunooncology agents such as IL-12, to promote local effector anti-tumor T cell responses • Combination therapy with anchored drugs can further drive therapeutic responses without…Read more

day: Day Two